- Home
- CCM vs BOLT Comparison
CCM vs BOLT Comparison
Compare CCM & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- BOLT
- Stock Information
- Founded
- CCM 1997
- BOLT 2015
- Country
- CCM China
- BOLT United States
- Employees
- CCM N/A
- BOLT N/A
- Industry
- CCM Medical/Nursing Services
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- BOLT Health Care
- Exchange
- CCM Nasdaq
- BOLT Nasdaq
- Market Cap
- CCM 18.2M
- BOLT 16.8M
- IPO Year
- CCM 2009
- BOLT 2021
- Fundamental
- Price
- CCM $4.13
- BOLT $0.40
- Analyst Decision
- CCM
- BOLT Hold
- Analyst Count
- CCM 0
- BOLT 5
- Target Price
- CCM N/A
- BOLT $1.13
- AVG Volume (30 Days)
- CCM 9.6K
- BOLT 146.3K
- Earning Date
- CCM 04-21-2025
- BOLT 05-13-2025
- Dividend Yield
- CCM N/A
- BOLT N/A
- EPS Growth
- CCM N/A
- BOLT N/A
- EPS
- CCM N/A
- BOLT N/A
- Revenue
- CCM $64,910,622.00
- BOLT $7,690,000.00
- Revenue This Year
- CCM N/A
- BOLT N/A
- Revenue Next Year
- CCM N/A
- BOLT $77.45
- P/E Ratio
- CCM N/A
- BOLT N/A
- Revenue Growth
- CCM N/A
- BOLT N/A
- 52 Week Low
- CCM $3.80
- BOLT $0.38
- 52 Week High
- CCM $26.70
- BOLT $1.48
- Technical
- Relative Strength Index (RSI)
- CCM 45.62
- BOLT 40.42
- Support Level
- CCM $3.90
- BOLT $0.38
- Resistance Level
- CCM $4.40
- BOLT $0.47
- Average True Range (ATR)
- CCM 0.42
- BOLT 0.04
- MACD
- CCM 0.02
- BOLT -0.00
- Stochastic Oscillator
- CCM 30.84
- BOLT 18.81
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.